Business · 28/08/1998
FDA Approves New Dosage Form for Neomycin Sulfate to Treat Colibacillosis in Livestock
The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplemental application by Phoenix Scientific, Inc. for a new dosage form of neomycin sulfate to treat colibacillosis in cattle, pigs, sheep, and goats.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →